← Leaderboards
Mark Ricigliano
Sloan-Kettering Inst Can Research
$567,068
Attributed
$1,134,136
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $576K · FY2016–17$1M$750K$500K$250K$0
'16
'17
Funding mix
By agency
NIH$1,134,136 · 1
By mechanism
R01$1,134,136 · 1
Top collaborators
- Kenneth H. Yu2 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Jason S Lewis$26,024,327
- Charles L Sawyers$34,701,646
- Kenneth H. Yu$4,069,136
- Michelle S Bradbury$7,087,200
- Taha Merghoub$4,342,237
Others in their field
Top investigators on “Biobank”
- Leonard Freedman · Leidos Biomedical Research, Inc.$247,215,881
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Peter J O'Dwyer · University Of Pennsylvania$120,526,242
- David Heimbrook · Leidos Biomedical Research, Inc.$115,298,400
- Praduman Jain · Vignet, Inc.$102,576,382
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,456,386
Research focus
BiobankBaseBiologyBiopsyBloodBiological Response Modifier TherapyCancer EtiologyCellsCessation Of LifeChemotherapyChemotherapy-Oncologic ProcedureClinical TrialsCollaborationsBlood TestsColorectal CancerDeath RateDisease ProgressionEarly DiagnosisEffective TherapyFutureGemcitabineGenesGeneticGenomics